Christopher Chope: I warmly congratulate my right hon. Friend on her new role. Will it include the possibility of re-examining the vaccine damage payment scheme, which has been described at the public inquiry as not fit for purpose? The £120,000 maximum payment has not been increased since 2007, and the 60% disability threshold is causing a massive injustice. Will she address those issues, please?
John Griffiths: ...especially in places like Liswerry and Maindee, where there is a high percentage of ethnic minority households. And we had an interesting experience with those communities around trying to improve vaccine take-up and general access to healthcare during the pandemic, and that has had a continuing legacy afterwards. During the pandemic, we had the emergence of Muslim Doctors Cymru, which was...
Mark Drakeford: ...take it when we don’t like the advice, because otherwise, the system is broken. And that’s always been the case in health; not just with NICE but with organisations like the Joint Committee on Vaccination and Immunisation. We’ve had many questions on the floor here about whether we could support a vaccine for this condition, and so on. We take the advice of the JCVI. If they say we...
Maria Caulfield: ...it difficult to ask for help, but if it is available on the website, they can do that in the privacy of their own home and know that the information is reliable. We are also now rolling out the HPV vaccine to boys. While we hope that vaccine will help us eradicate cervical cancer, we know that some male cancers—particularly oral cancers—are related to HPV, so rolling out the vaccine to...
Alex Burghart: ...across Government and informed the wider intelligence picture across public sector organisations. It has also contributed to media campaigns providing guidance in relation to Covid Pass fraud, vaccine fraud and phishing.
Fulton MacGregor: .... People in Scotland were asked to make sacrifices to ensure that those who were most vulnerable were shielded from the worst of the pandemic before the heroic effort to develop and procure a vaccine was completed. Despite those efforts, many families found themselves bereaved because of the pandemic—my sympathies go to John Mason, who shared his own story today. Many more are still...
Lord Bilimoria: ...the Serum Institute of India, and a fellow Zoroastrian and Parsee. On that day I spoke to Professor Sir Adrian Hill, who told me of the amazing work they were doing in a race to develop a malaria vaccine, working very closely with the Serum Institute of India to achieve this. This year, we heard the great news that this vaccine has now been approved. It is 75% effective, it is cheaper than...
Ben Lake: To ask the Secretary of State for Health and Social Care, whether he has plans to expand the eligibility criteria for the Pfizer Covid-19 vaccine; and what guidance his Department has issued on the additional protection provided by additional doses and any related health implications.
Baroness Penn: ...of us. We are ranked number one by the World Bank among major European economies as a place to do business. We are home to Europe’s largest life sciences sector, which helped produce a Covid vaccine that saved 6 million lives and a treatment that saved 1 million more. We are only the third country in the world to have developed a trillion-dollar tech economy. Our film and TV industries...
Preet Kaur Gill: To ask the Secretary of State for Health and Social Care, whether people aged between 66 and 69 on 1 September 2023 are eligible for the shingles vaccine.
Luke Evans: ...technology is already out there—that is the problem. How quickly will the safety institute be set up, and most importantly, how quickly will we see tangible results? Can we learn lessons from the vaccine, and from the Medicines and Healthcare products Regulatory Agency on how legislation and regulation can run alongside innovation in this sector?
Jack Brereton: To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of the (a) UK’s vaccine vial production capability, (b) reliance of the UK on the import of medical grade vials and (c) security of UK supply chains in the event of a future pandemic.
Andrew Mitchell: ...dramatically impacted global health and immunisation. The UK Government is committed to supporting efforts to get routine immunisation back on track and has invested £1.65 billion to Gavi, the Vaccine Alliance from 2021-2025 to support their mission to immunise 300 million children and save up to 8 million lives from vaccine preventable diseases over this period. The UK has supported Gavi...
Jack Brereton: To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the (a) adequacy of the UK’s vaccine vial production capability, (b) reliance of the UK on the import of medical grade vials and (c) security of UK supply chains in the event of a future pandemic.
Matthew Hancock: To ask the Secretary of State for Health and Social Care, when he plans to publish a vaccine strategy.
Baroness Ritchie of Downpatrick: To ask His Majesty's Government whether, following the recent recommendation by the World Health Organization on the R21 malaria vaccine, they intend to provide sufficient funding to (1) Gavi, the Vaccine Alliance, (2) the Global Fund to Fight AIDS, Tuberculosis and Malaria, and (3) Unitaid, over their next funding cycles to ensure that vaccines and other life-saving tools can be delivered...
Lord Weir of Ballyholme: To ask His Majesty's Government what COVID-19 vaccine availability there will be for private health care for groups such as (1) children, and (2) other categories not specifically prioritised for government roll out, in 2024.
Lord Weir of Ballyholme: To ask His Majesty's Government what research they are undertaking to determine the reasons for vaccine hesitancy amongst communities or sections of society with traditionally low take-up; and what steps they are undertaking to combat such hesitancy.
Lord Taylor of Warwick: ...of the Nature article Learning from prepandemic data to forecast viral escape, published on 11 October, about the use of artificial intelligence as a tool to predict virus variants and aid in vaccine developments.
Baroness Ritchie of Downpatrick: To ask His Majesty's Government what support they are providing to UK life sciences and investment in the innovation pipeline to build on recent successes such as the development of a malaria vaccine by the Oxford-based Jenner Institute.